3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Colorectal Neoplasms
30
Rectal Neoplasms
7
Colonic Neoplasms
7
Carcinoma, Hepatocellular
7
Neoplasm Metastasis
5
Cholangiocarcinoma
5
Stomach Neoplasms
4
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Biliary Tract Neoplasms
3
Adenocarcinoma Of Esophagus
3
Ovarian Neoplasms
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Solid Tumors
1
Recurrence
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Locally Advanced Rectal Cancer
1
Locally Advanced Colorectal Carcinoma
1
Liver Neoplasms
1
Gastroesophageal Junction Adenocarcinoma
1
Gastroesophageal Adenocarcinoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Endometrial Neoplasms
1
Disease Progression
1
Colorectal Cancer Metastatic
1
Interventions
pembrolizumab
90
Blood Specimen Collection
44
Cyclophosphamide
37
Nivolumab
35
Bevacizumab
35
Standard of Care
32
Carboplatin
30
Surveys and Questionnaires
29
Paclitaxel
28
atezolizumab
24
Pemetrexed
24
Gemcitabine
24
Exercise
24
Fluorouracil
23
Cisplatin
23
Leucovorin
21
Dexamethasone
20
Radiotherapy
19
Oxaliplatin
19
Docetaxel
19
Rituximab
16
Irinotecan
16
Cetuximab
16
dostarlimab
15
Ipilimumab
15
Doxorubicin
15
Biopsy
15
130-nm albumin-bound paclitaxel
15
Drug Therapy
14
fludarabine
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Neoplasms
×
Folfox protocol
×
1 year
×
Clear all
NCT06846346
2026-04-28
GRACIE
UNICANCER
Phase 2
Recruiting
88 enrolled
NCT06475352
2026-04-23
FUDOSE
UNICANCER
Phase 2
Recruiting
400 enrolled
NCT02967289
2025-11-17
IROCAS
UNICANCER
Phase 3
Completed
792 enrolled